JNCE
Goldman Sachs’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-42,922
| Closed | -$79.4K | – | 5293 |
|
2023
Q1 | $79.4K | Sell |
42,922
-83,824
| -66% | -$155K | ﹤0.01% | 4699 |
|
2022
Q4 | $141K | Sell |
126,746
-34,773
| -22% | -$38.6K | ﹤0.01% | 4598 |
|
2022
Q3 | $378K | Sell |
161,519
-43,114
| -21% | -$101K | ﹤0.01% | 4416 |
|
2022
Q2 | $620K | Sell |
204,633
-187,283
| -48% | -$567K | ﹤0.01% | 4240 |
|
2022
Q1 | $2.66M | Sell |
391,916
-328,529
| -46% | -$2.23M | ﹤0.01% | 3336 |
|
2021
Q4 | $6.02M | Buy |
720,445
+46,519
| +7% | +$388K | ﹤0.01% | 2658 |
|
2021
Q3 | $5.01M | Buy |
673,926
+509,577
| +310% | +$3.79M | ﹤0.01% | 2794 |
|
2021
Q2 | $1.12M | Buy |
164,349
+13,038
| +9% | +$88.7K | ﹤0.01% | 3941 |
|
2021
Q1 | $1.55M | Buy |
151,311
+115,764
| +326% | +$1.19M | ﹤0.01% | 3596 |
|
2020
Q4 | $249K | Sell |
35,547
-2,540
| -7% | -$17.8K | ﹤0.01% | 4168 |
|
2020
Q3 | $310K | Sell |
38,087
-18,785
| -33% | -$153K | ﹤0.01% | 3889 |
|
2020
Q2 | $392K | Sell |
56,872
-23,090
| -29% | -$159K | ﹤0.01% | 3708 |
|
2020
Q1 | $380K | Sell |
79,962
-31,004
| -28% | -$147K | ﹤0.01% | 3632 |
|
2019
Q4 | $969K | Sell |
110,966
-25,823
| -19% | -$225K | ﹤0.01% | 3350 |
|
2019
Q3 | $456K | Buy |
136,789
+43,114
| +46% | +$144K | ﹤0.01% | 3638 |
|
2019
Q2 | $464K | Buy |
93,675
+3,374
| +4% | +$16.7K | ﹤0.01% | 3558 |
|
2019
Q1 | $560K | Sell |
90,301
-4,921
| -5% | -$30.5K | ﹤0.01% | 3520 |
|
2018
Q4 | $321K | Sell |
95,222
-6,516
| -6% | -$22K | ﹤0.01% | 3574 |
|
2018
Q3 | $661K | Buy |
101,738
+17,742
| +21% | +$115K | ﹤0.01% | 3346 |
|
2018
Q2 | $643K | Buy |
83,996
+7,216
| +9% | +$55.2K | ﹤0.01% | 3415 |
|
2018
Q1 | $1.72M | Buy |
76,780
+14,993
| +24% | +$335K | ﹤0.01% | 2948 |
|
2017
Q4 | $788K | Sell |
61,787
-53,175
| -46% | -$678K | ﹤0.01% | 3248 |
|
2017
Q3 | $1.79M | Buy |
114,962
+45,314
| +65% | +$706K | ﹤0.01% | 2941 |
|
2017
Q2 | $977K | Buy |
69,648
+57,336
| +466% | +$804K | ﹤0.01% | 3163 |
|
2017
Q1 | $271K | Buy |
+12,312
| New | +$271K | ﹤0.01% | 3825 |
|